AI brief of an SEC Form 8-K · GeoVax Labs, Inc. (GOVX)

GeoVax Labs receives Nasdaq delisting determination; plans to request hearing by Sept. 3

Negative Impact 5 of 5 legal/regulatory Written later

GeoVax Labs received a Nasdaq Staff Determination Letter on August 27, 2026, stating Nasdaq will delist its common stock because the bid price stayed below $1.00 and the company is not eligible for the customary 180-day compliance period after its January 2026 reverse split. The company plans to request a hearing before the Nasdaq Hearings Panel, which would stay further action and keep the stock trading during the appeal, but the filing says there is no assurance the panel will grant continued listing.

Key points

  • Nasdaq determined the closing bid price was below $1.00 for 30 consecutive business days from July 16, 2026 through August 26, 2026.
  • The company effected a 1-for-25 reverse stock split on January 12, 2026, which made it ineligible for the 180-day compliance period.
  • Absent a timely hearing request, trading is expected to be suspended at the opening of business on September 8, 2026; the hearing request deadline is September 3, 2026.

The filing

CompanyGeoVax Labs, Inc. (GOVX)
Form8-K, current report
Filed with the SECAug 28, 2026, 4:16 PM ET
Accession number0001437749-26-029184

Items reported: 3.01 Delisting / Listing Rule Notice

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 28, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.